Medindia

X

Verdict On First Drug To Avert HIV Infection Deferred by FDA

by Nancy Needhima on  June 11, 2012 at 2:29 PM AIDS/HIV News   - G J E 4
A decision on whether to approve Truvada as the first pill that prevents HIV infection is postponed until mid-September by US health regulators.
Verdict On First Drug To Avert HIV Infection Deferred by FDA
Verdict On First Drug To Avert HIV Infection Deferred by FDA
Advertisement

Drug maker Gilead Sciences said on Friday that the Food and Drug Administration (FDA) would take an additional three months to review its drug application, after the California Company submitted additional materials to the agency earlier this month.

Advertisement
In May, a panel of experts recommended approval of the daily pill for healthy people at high risk of contracting HIV, the Daily Express reported.

The group's vote is non-binding, but the FDA often follows its advice.

Gilead said that it had submitted updated details on its safety materials for patients and doctors using Truvada.

The FDA typically extends its reviews after receiving such information.

Source: ANI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All